XETRA - Delayed Quote EUR
BB Biotech AG Ord (BBZA.DE)
30.20
-0.10
(-0.33%)
At close: April 25 at 5:35:56 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
146,175
218,276
231,131
-94,787
262,449
Financing Cash Flow
-144,090
-220,213
-233,271
91,768
-284,483
End Cash Position
2,407
501
1,948
2,835
6,816
Issuance of Capital Stock
--
--
--
9,653
20
Issuance of Debt
--
--
8,000
292,000
--
Repayment of Debt
-27,800
-58,100
--
--
-87,000
Repurchase of Capital Stock
-813
--
-27,303
-9,459
-8,260
Free Cash Flow
146,175
218,276
231,131
-94,787
262,449
12/31/2020 - 1/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FYB.DE Formycon AG
23.05
+1.32%
88Q.DE 4basebio PLC
12.90
0.00%
7V0.DE Darwin AG
27.40
0.00%
AYJ.DE Valneva SE
3.1560
+0.32%
NVV1.DE Novavax, Inc.
7.85
-0.53%
VX1.DE Vertex Pharmaceuticals Incorporated
430.90
-0.29%
BIO3.DE Biotest Aktiengesellschaft
30.20
0.00%
BIO.DE Biotest Aktiengesellschaft
42.40
0.00%
9VC.DE Atai Life Sciences N.V.
1.3155
-2.01%
NP5.DE Newron Pharmaceuticals S.p.A.
7.51
-1.57%